01 47GILEAD SCIENCES INC
01 27964580
02 28334270
03 28575135
04 28580765
05 28618076
06 28633309
07 28735372
08 28889159
09 28921341
10 28940718
11 28957046
12 29085573
13 29284342
14 19296782
15 19868745
16 110912814
17 211116783
18 111116783*PED
19 211338007
20 111338007*PED
21 17964580*PED
22 18334270*PED
23 18575135*PED
24 18580765*PED
25 18618076*PED
26 18633309*PED
27 18735372*PED
28 18889159*PED
29 18921341*PED
30 18940718*PED
31 19085573*PED
32 19284342*PED
01 26Y
02 21Blank
01 31Y
02 16Blank
01 102028-03-21
02 42028-09-21
03 62029-03-26
04 32029-09-26
05 22030-09-13
06 22030-12-11
07 12031-03-13
08 12031-06-11
09 72032-11-16
10 32033-05-16
11 22034-01-30
12 12034-07-17
13 12034-07-30
14 32037-06-01
15 12037-12-01
Patent Expiration Date : 2032-11-16
SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR
US Patent Number : 8940718
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 209195
Patent Use Code : U-2039
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-11-16
Patent Expiration Date : 2032-11-16
SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR
US Patent Number : 8575135
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 209195
Patent Use Code : U-2040
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-11-16
Patent Expiration Date : 2032-11-16
SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR
US Patent Number : 8921341
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 209195
Patent Use Code : U-2040
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-11-16
Patent Expiration Date : 2032-11-16
SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR
US Patent Number : 8921341
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 209195
Patent Use Code : U-2039
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-11-16
Patent Expiration Date : 2029-03-26
SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR
US Patent Number : 7964580
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 209195
Patent Use Code : U-2039
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-03-26
Patent Expiration Date : 2029-03-26
SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR
US Patent Number : 7964580
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 209195
Patent Use Code : U-2040
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-03-26
Patent Expiration Date : 2030-12-11
SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR
US Patent Number : 8618076
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 209195
Patent Use Code : U-2040
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-12-11
Patent Expiration Date : 2028-03-21
SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR
US Patent Number : 9085573
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 209195
Patent Use Code : U-2040
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-03-21
Patent Expiration Date : 2028-03-21
SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR
US Patent Number : 9085573
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 209195
Patent Use Code : U-2039
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-03-21
Patent Expiration Date : 2028-03-21
SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR
US Patent Number : 8334270
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 209195
Patent Use Code : U-2040
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-03-21
LOOKING FOR A SUPPLIER?
